4Accepted Sep 10, 4:02 PM ET
SOPHiA GENETICS (SOPH) Director Kathy Hibbs Sells Shares
Accepted (ET)
4:02 PM
Sep 10, 2026
Filed
Sep 10, 2026
Documents
1
Size
5.3 KB
Summary
SOPHiA GENETICS (SOPH) Director Kathy Hibbs Sells Shares
What Happened
Kathy L. Hibbs, a Director of SOPHiA GENETICS SA (SOPH), sold 6,250 shares of SOPH stock on 2026-09-08 for total proceeds of approximately $50,818. The filing reports a weighted-average sale price of $8.13 per share (total value ≈ $50,818). This transaction is a sale (not a purchase or option exercise).
Key Details
- Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (two days after the trade).
- Price: weighted average $8.13; individual trade prices ranged from $7.90 to $8.35.
- Shares sold: 6,250; proceeds ≈ $50,818.
- Shares owned after transaction: not specified in the supplied filing details.
- Footnotes: (F1) Sale was made pursuant to a duly adopted Rule 10b5-1(c) trading plan. (F2) Reported price is a weighted average; the filer can provide the number of shares sold at each separate price on request.
- Filing timeliness: filed two days after the trade (within the typical two-business-day Form 4 window based on provided dates).
Context
Sales executed under Rule 10b5-1 plans are pre-arranged and commonly used to manage insider liquidity while limiting concerns about trading on material non-public information. A sale does not, by itself, indicate the insider's view of the company's prospects.